PRTG

Portage Biotech (PRTG)

About Portage Biotech (PRTG)

Portage Biotech, Inc. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. Its portfolio includes first-in-class invariant natural killer T cell (iNKT) small molecule engagers and best-in-class adenosine antagonists. The company was founded by Gregory H. Bailey and James Mellon in 1973 and is headquartered in Road Town, British Virgin Islands.

Details

Daily high

$7.45

Daily low

$6.70

Price at open

$7.05

52 Week High

$53.20

52 Week Low

$2.10

Market cap

4.7M

Dividend yield

0.00%

Volume

35,236

Avg. volume

2.8M

P/E ratio

-.10

Portage Biotech News